Genpharmasec

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE861N01036
  • NSEID:
  • BSEID: 531592
INR
1.15
0.03 (2.68%)
BSENSE

Sep 25, 03:30 PM

BSE+NSE Vol: 3.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 329838,
    "name": "Genpharmasec",
    "stock_name": "Genpharmasec",
    "full_name": "Genpharmasec Ltd",
    "name_url": "stocks-analysis/genpharmasec",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.15",
    "chg": 0.03,
    "chgp": "2.68%",
    "dir": 1,
    "prev_price": "1.12",
    "mcapval": "62.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531592,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "sector_id": 79,
    "indexname": "India SENSEX",
    "isin": "INE861N01036",
    "curr_date": "Sep 25, 03:30 PM",
    "curr_time": "21:51 PM",
    "last_traded_at": "Sep 25, 03:30 PM IST",
    "bse_nse_vol": "3.27 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genpharmasec-329838-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4196297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GenpharmasecLtd_mojoScore_4196297.png",
        "date": "2026-09-17 10:10:04",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 17 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4182466",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/GenpharmasecLtd_mojoScore_4182466.png",
        "date": "2026-09-04 10:10:27",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025, reflecting a shift from a previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4161101",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GenpharmasecLtd_mojoScore_4161101.png",
        "date": "2026-08-19 10:10:33",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Genpharmasec Ltd Reports Positive Quarterly Growth Amidst Lingering Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-reports-positive-quarterly-growth-amidst-lingering-market-challenges-4148966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GenpharmasecLtd_fintrenddot_4148966.png",
        "date": "2026-08-12 08:00:14",
        "description": "Genpharmasec Ltd has delivered a notably positive financial performance in the quarter ended June 2026, with net sales surging 42.1% compared to the previous four-quarter average and a higher PAT of ₹1.75 crores over the last six months. Despite this encouraging quarterly momentum, the company continues to face significant headwinds reflected in its long-term returns and a recent downgrade to a Strong Sell rating by MarketsMOJO."
      },
      {
        "title": "When is the next results date for Genpharmasec Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-genpharmasec-ltd-4136298",
        "imagepath": "",
        "date": "2026-08-04 23:18:10",
        "description": "The next results date for Genpharmasec Ltd is scheduled for 11 August 2026...."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4135068",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GenpharmasecLtd_mojoScore_4135068.png",
        "date": "2026-08-04 10:10:22",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4112493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GenpharmasecLtd_mojoScore_4112493.png",
        "date": "2026-07-21 10:10:04",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4096387",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GenpharmasecLtd_mojoScore_4096387.png",
        "date": "2026-07-10 10:10:04",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4076970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GenpharmasecLtd_mojoScore_4076970.png",
        "date": "2026-06-29 10:10:05",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 5442,
    "sid": "329838",
    "stock_news_url": "https://www.marketsmojo.com/news/genpharmasec-329838"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Sep-2026",
      "details": "Newspaper Publication of Notice of AGM to be held on 29th September 2026.",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "07-Sep-2026",
      "details": "Annual Report for Financial Year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Notice Of The 34Th Annual General Meeting Of The Company To Be Held On September 29 2026.",
      "datetime": "07-Sep-2026",
      "details": "Notice of 34th Annual General Meeting of the company to be held on September 29 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Apr 19",
          "dt": "2019-04-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 09 Jan 24",
          "dt": "2024-01-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

08-Sep-2026 | Source : BSE

Newspaper Publication of Notice of AGM to be held on 29th September 2026.

Reg. 34 (1) Annual Report.

07-Sep-2026 | Source : BSE

Annual Report for Financial Year 2025-26.

Notice Of The 34Th Annual General Meeting Of The Company To Be Held On September 29 2026.

07-Sep-2026 | Source : BSE

Notice of 34th Annual General Meeting of the company to be held on September 29 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Genpharmasec Ltd has announced 1:10 stock split, ex-date: 11 Apr 19

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Genpharmasec Ltd has announced 1:1 rights issue, ex-date: 09 Jan 24

Footer loading
Genpharmasec Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues